Physician profile
Thomas Giudice
NPI 1497735757
$418,123.52
in general payments reported to CMS, 2019-2025
45 companies · $48K in 2025
The $48K reported for 2025 was more than what 98% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133K · 2020: $45K · 2021: $26K · 2022: $62K · 2023: $66K · 2024: $38K · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $112K · Consulting Fee: $20K · Travel and Lodging: $15K · Food and Beverage: $4,890 · Education: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $112,075.00 |
| Consulting Fee | $20,316.00 |
| Travel and Lodging | $14,538.08 |
| Food and Beverage | $4,889.71 |
| Education | $327.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $341,668.57 | 2019-2025 | Solyx Sis System, Upsylon, Advantage System |
| Valencia Technologies Corporation | $38,805.65 | 2022-2025 | Ecoin Device Kit |
| Coloplast Corp | $29,089.49 | 2019-2025 | |
| Axonics, INC. | $1,574.20 | 2022-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $1,223.73 | 2021-2025 | Interstim |
| Applied Medical Resources Corporation | $849.14 | 2024 | Gelpoint V-Path |
| Astellas Pharma US INC | $736.29 | 2019-2023 | Veozah, Myrbetriq |
| Abbvie INC. | $615.79 | 2019-2025 | |
| Intuitive Surgical, INC. | $609.24 | 2019-2024 | Da Vinci Surgical System |
| Medtronic USA, INC. | $489.30 | 2019-2020 | |
| Caldera Medical, INC | $364.46 | 2022-2023 | Desara |
| Myovant Sciences INC. | $233.74 | 2022 | |
| Duchesnay USA Incorporated | $186.72 | 2019 | |
| Pfizer INC. | $183.81 | 2019-2024 | |
| Aspira Women'S Health INC | $183.81 | 2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Giudice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.